Ulta Beauty (ULTA) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Ulta Beauty, Inc. (ULTA) insider buying and selling: no purchases, 5 sales
27 Form 4 Table I transactions filed with the SEC by Ulta Beauty, Inc. insiders between 2025-09-03 and 2026-09-21 (15-month history): 0 open-market purchases and 5 sales, plus 22 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $1.1M by Steelman Kecia on 2026-09-17.
Ulta Beauty insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Ulta Beauty insiders filed 4 sales worth $1.8M on the open market, and no purchases.
The biggest seller was Steelman Kecia (President and CEO): $1.1M in 1 sale, out of 3 different sellers.
The largest trade of the period was a sale of $1.1M on Sep 17, 2026, by Steelman Kecia (President and CEO). Form 4 on sec.gov (0000897069-26-001790).
None of the 4 sales carries the 10b5-1 plan flag on the Form 4 (sales scheduled months ahead).
The last three months show 2 sales, against 1 in the three before. The latest sale from Sep 17, 2026.
Against its sector (Consumer Cyclical, 54 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Ulta Beauty has more sales than 11 of the other 53, ranks 40 of 54 by net dollars sold, and 18 of the 54 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with ULTA's sales, largest first. The full history is in the tool above, already searched.
See all 27 ULTA trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-21 | Steelman Kecia | President and CEO | $1.1M | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. The prices actually received ranged from $545.8201 to $546.0600. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price | SEC |
| 2026-09-11 | 2026-09-14 | Nagler Lorna | Director | $322k | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. The prices actually received ranged from $536.92 to $537.84. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price. | SEC |
| 2025-09-04 | 2025-09-08 | Smith Mike C. | Director | $264k | S — Open-market sale | SEC |
| 2026-04-07 | 2026-04-07 | Mrkonic George R Jr | Director | $244k | S — Open-market saleForm 4 footnoteF1 The price reported in Column 4 is a weighted average price. The prices actually received ranged from $538.29 to $539.51. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price. | SEC |
| 2026-06-15 | 2026-06-16 | Mrkonic George R Jr | Director | $182k | S — Open-market sale | SEC |
| 2026-03-15 | 2026-03-17 | Steelman Kecia | President and CEO | $1.0M | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock grants previously reported. F2 Represents the number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting of performance based restricted stock grants previously reported. | SEC |
| 2026-03-15 | 2026-03-17 | Ryan Anita Jane | Chief Human Resources Officer | $144k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 Represents the number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting of restricted stock grants previously reported. F2 Represents the number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting of performance based restricted stock grants previously reported. | SEC |
| 2026-09-01 | 2026-09-03 | Garcia Kelly E | Chief Technology Officer | A — Grant or awardForm 4 footnoteF1 Represents a grant of 2,933 restricted stock units, with 37.5% vesting on March 15, 2028, 37.5% vesting on March 15, 2029, and the remaining 25% vesting on September 1, 2031. | SEC | |
| 2026-09-01 | 2026-09-02 | Olson Brieane Lee | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 271 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Brok Martin | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Garcia Kelly E | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Halligan Catherine Ann | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Landry Stephenie Lee | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Mrkonic George R Jr | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Nagler Lorna | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-06-10 | 2026-06-11 | Smith Mike C. | Director | A — Grant or awardForm 4 footnoteF1 Represents a grant of 404 restricted stock units, vesting 100% on 6/10/2027. | SEC | |
| 2026-03-31 | 2026-04-02 | Casares Rene G. | Chief Legal Officer | A — Grant or awardForm 4 footnoteF1 Represents grant of 1,263 shares of restricted stock, vesting 100% on March 15, 2029. | SEC | |
| 2026-03-31 | 2026-04-02 | Delorefice Christopher | Chief Financial Officer | A — Grant or awardForm 4 footnoteF1 Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029. | SEC | |
| 2026-03-31 | 2026-04-02 | Ryan Anita Jane | Chief Human Resources Officer | A — Grant or awardForm 4 footnoteF1 Represents grant of 1,443 shares of restricted stock, vesting 100% on March 15, 2029. | SEC | |
| 2026-03-31 | 2026-04-02 | Steelman Kecia | President and CEO | A — Grant or awardForm 4 footnoteF1 Represents grant of 10,889 shares of restricted stock, vesting 100% on March 15, 2029. | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Sep 3, 2025 and Sep 21, 2026 there is not one open-market purchase of Ulta Beauty, Inc.: 5 sales worth $2.1M and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Ulta Beauty, Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 19 | $0 |
| S | Open-market sale | 5 | $2.1M |
| F | Tax withholding (shares surrendered for taxes) | 2 | $1.2M |
| G | Gift | 1 | $0 |
| Total | Everything filed in the period | 27 | $3.3M |
20 of the 27 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 13 distinct people or entities have filed Ulta Beauty, Inc. transactions: none bought on the open market and 4 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Steelman Kecia | President and CEO | 4 | — | $1.1M (1) | 2026-09-21 |
| Mrkonic George R Jr | Director | 3 | — | $426k (2) | 2026-06-16 |
| Nagler Lorna | Director | 2 | — | $322k (1) | 2026-09-14 |
| Smith Mike C. | Director | 2 | — | $264k (1) | 2026-06-11 |
| Ryan Anita Jane | Chief Human Resources Officer | 3 | — | — | 2026-04-02 |
| Brok Martin | Director | 2 | — | — | 2026-06-11 |
| Delorefice Christopher | Chief Financial Officer | 2 | — | — | 2026-04-02 |
| Garcia Kelly E | Chief Technology Officer | 2 | — | — | 2026-09-03 |
Shown here are the 8 who moved the most money, out of 13. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Sep 2026: 0 purchases and 2 sales, worth $1.4M. 11 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 1 | $264k |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 0 | $0 |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 1 | $244k |
| May 2026 | 0 | $0 | 0 | $0 |
| Jun 2026 | 0 | $0 | 1 | $182k |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 2 | $1.4M |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Ulta Beauty, Inc. (ULTA) analysis page →
Other Consumer Cyclical companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 5 sales in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. Ulta Beauty has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Sep 21, 2026, and a Form 4 arrives up to two business days after the trade.
18 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.